Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05042388 · ClinicalTrials.gov registry record · NA
Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder
A NA study, sponsored by West Chester University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT05042388 is a NA study that has completed, run by West Chester University of Pennsylvania. The registered enrollment target is 105 participants.
The verdict
NCT05042388, a NA study, has completed, sponsored by West Chester University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This proposal aims to determine whether an adjunctive Mindfulness-Based Relapse Prevention (MBRP) treatment program improves Medication Assisted Treatment (MAT) adherence and reduces drug-use among opioid use disorder (OUD) patients. The broad long-term objectives of this project are to investigate how integrative pharmacological and behavioral treatments improve OUD treatment outcomes. This study aims to include 200 patients diagnosed with with opioid use disorder (OUD), that are enrolled in a \~60-day residential addiction treatment program. Participant recruitment will prioritize participants that are prescribed MAT for OUD. Participants will be randomly assigned to a MBRP behavioral treatment condition or a non-MBRP treatment-as-usual (TAU) control condition as part of their treatment within the residential addiction treatment program. All participants will be monitored for three-months following their discharge from the program to test the hypotheses that MBRP participants, relative to TAU participants, will (1) demonstrate greater MAT adherence following discharge, and (2) evidence reduced drug-use following discharge.
Interventions
- BEHAVIORAL Mindfulness-Based Relapse Prevention - Rolling Admission (MBRP-RA)
- BEHAVIORAL Treatment-As-Usual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2024-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05042388
The ClinicalTrials.gov registry entry for NCT05042388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Chester University of Pennsylvania, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mindfulness-Based Relapse Prevention - Rolling Admission (MBRP-RA) is the first listed.
NCT05042388 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05042388 about?
NCT05042388 is a clinical study titled "Mindfulness-Based Relapse Prevention to Improve Medication Assisted Treatment Adherence and Drug-use Outcomes for Opioid Use Disorder". This proposal aims to determine whether an adjunctive Mindfulness-Based Relapse Prevention (MBRP) treatment program improves Medication Assisted Treatment (MAT) adherence and reduces drug-use among opioid use disorder (OUD) patients. The broad long-term objectives of this project are to investigate ...
What is the current status of trial NCT05042388?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2021-08-01. Estimated completion is 2024-08-20.
What interventions are being tested in trial NCT05042388?
The interventions under investigation include: Mindfulness-Based Relapse Prevention - Rolling Admission (MBRP-RA) (BEHAVIORAL), Treatment-As-Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT05042388?
This trial is sponsored by West Chester University of Pennsylvania, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.